Registry study on the life cycle of patients with congenital heart disease
Official title: A Comprehensive Registry Study of the Whole Life Cycle of Patients With Congenital Heart Diseases
Run by Beijing Anzhen Hospital · NCT06611787 · Data updated 2026-11-12
This study looks at how congenital heart disease affects patients in China from pregnancy through their entire lives to see how to improve their care and treatment.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 100000 (estimated) |
| Sponsor | Beijing Anzhen Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | February 2, 2024 |
| Main results expected | January 1, 2029 |
| Study ends | January 1, 2030 |
| Registry record updated | September 25, 2024 |
| Trial ID | NCT06611787 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients diagnosed with various forms of congenital heart disease.
✕Probably not a fit
Patients with congenital heart disease who are not receiving treatment or intervention may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study collects data on the prevalence, interventions, and prognosis of congenital heart disease (CHD) in Chinese patients throughout their lives. It covers the entire spectrum from fetal diagnosis to neonatal treatment and standardized care during pregnancy for CHD patients. The study employs a cyclical model of evaluation, training, improvement, and re-evaluation to enhance the diagnostic and treatment capabilities of participating hospitals, particularly for complex cases. The ultimate goal is to improve medical services and develop treatment guidelines for CHD in China.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and treatment standards for congenital heart disease in China.
How similar studies have gone: Other studies focusing on registry data for congenital heart disease have shown success in improving treatment outcomes and standardizing care.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with various congenital heart diseases Exclusion Criteria: * None
Where it's running
-
Beijing AnZhen Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: JiaChen Li, MD
- Email: lijiachen0915@126.com
- Phone: 18513494314
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Adapting and testing PEN-Plus in Zambian primary care
Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.
-
Wireless NIRS Sensor Use in the NICU for Monitoring on Neonates
A wireless NIRS sensor is tested on infants in the NICU to see how well it stays on and how it notes brain signals when used alongside standard wired sensors.
-
Screening for lipid disorders in children and teens with chronic diseases to flag cardiovascular risk
This study tests a blood test and a questionnaire to screen children and teens with chronic conditions for lipid metabolism disorders and familial hyperlipidemia.
-
Prehabilitation before heart surgery for adults with congenital heart disease
This study is testing whether a tailored, supervised exercise program before heart surgery helps adults with congenital heart disease perform better and improve fitness.
-
Accessible care model comparing nurse-led versus physician-led transition education for teens and young adults with congenital heart disease
This project will test whether an accessible care model and nurse-led versus physician-led transition education helps teens and young adults (ages 12–26) with congenital heart disease move successfully from pediatric to adult heart care.
-
Surgical techniques and outcomes across the lifespan in congenital heart disease in China
See which surgical factors and care patterns affect recovery after heart surgery for people with complex congenital heart disease in China.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.